Our increased awareness of the clonal organization of many hematological and solid cancers has dramatically changed our view on the design of novel therapeutic approaches for cancer. Tumor-initiating cells (TIC) (a.k.a. cancer stem cells) are on the apex in this hierarchy and can self-renew and differentiate, thereby continuously fueling tumor growth and metastasis formation. This process was previously thought to be unidirectional. Self-renewing TIC therefore represent highly attractive targets for therapeutic intervention.
See also: C Cortina et al (July 2017) F unctional heterogeneity in CRC is somewhat akin to the organization of the normal intestinal stem cell (ISC) compartment, where crypt-based columnar cells (CBCC) expressing the Wnt target gene LGR5 are responsible for tissue homeostasis and regeneration (Beumer & Clevers, 2016) . CBCC reside at the crypt base interspersed with, and in close contact to postmitotic Paneth cells, which constitute the stem cell niche for these LGR5 + ISC (Sato et al, 2011) . Compartmentalization of the intestinal crypt structure into a stem cell compartment at the base and a differentiated compartment at the intestinal villus or the colon surface is dependent on a Wnt gradient whose intensity is strongest at the crypt bottom. Active Wnt signaling is essential for stem cell maintenance and activity (Basu et al, 2016 (Dieter et al, 2011; Kreso et al, 2013) , and suggesting that such a population could fuel tumor growth following ablation of actively dividing cells. Moreover, it will be interesting to understand whether resting LGR5 + cells are similar to the reserve stem cell populations in normal human intestinal epithelium, which are considered to intervene during regeneration (Beumer & Clevers, 2016) . Given that organoid technology allows for manipulating normal and malignant ISC, the presented approach enables both directly comparing stem cell systems and assessing a potential therapeutic window based on selective gene dependencies. LGR5-lineage tracing
LGR5 + tumor cells drive liver metastasis Melo et al. (2017) LGR5 + tumor cells As demonstrated earlier by genetic barcoding, CRC TIC are critical for metastasis formation (Dieter et al, 2011) . Melo et al (2017) In summary, these exciting reports profoundly impact on our understanding of TIC hierarchies. Previously regarded as fixed populations, the functionally heterogeneous composition of a tumor bulk rather appears as a dynamic structure, where the loss of TIC can be compensated by reversal of differentiated cancer cells as required.
This raises several new fundamental questions. First, it remains to be clarified whether the reversal of differentiated cancer cells is a "democratic" process, whereby every cancer cell can become a TIC, or whether distinct cell subfractions can be recruited as has been shown for the normal intestinal epithelium. Moreover, the mechanisms contributing to the reversal process and inducing cancer stemness need to be deciphered in order to design therapeutic strategies that not only target TIC, but additionally interfere with their compensation mechanisms. Whether TIC eradication alone is sufficient to treat metastatic disease will have to be determined by analyzing metastatic sites beyond the liver and by understanding the role of different microenvironments in TIC compensation.
Collectively, these reports have revealed fascinating novel aspects of TIC biology, raised new questions to be answered and, importantly, presented the tools to address them. From a therapeutic perspective, it becomes evident that to succeed, future therapeutic strategies will need to target the mechanisms underlying TIC activity rather than TIC per se.
